Profiting from the Pandemic: Will Pharmaceutical Giants Use Patents to Limit Access to COVID Drugs?
Автор: Democracy Now!
Загружено: 2020-05-07
Просмотров: 19548
As the number of confirmed COVID-19 cases worldwide approaches 4 million and the pandemic could be with us for months or years, we look at who can access drugs like remdesivir, being developed by pharmaceutical giant Gilead, which has the patent for the drug and is poised to make massive profits. We look at how much drugs like remdesivir will cost, and who can access them, with writer Achal Prabhala, coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa.
#DemocracyNow
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: https://democracynow.org
Please consider supporting independent media by making a donation to Democracy Now! today: https://democracynow.org/donate
FOLLOW DEMOCRACY NOW! ONLINE:
YouTube: / democracynow
Facebook: / democracynow
Twitter: / democracynow
Instagram: / democracynow
SoundCloud: / democracynow
iTunes: https://itunes.apple.com/podcast/demo...
Daily Email Digest: https://democracynow.org/subscribe
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
